Archives202520242023202220212020201920182017201620152014201320122011 September 19, 2018Standford Capital Partners and Si Capital are appointed as joint broker Read More June 29, 20182018 Annual General Meeting – All Resolutions Passed Read More June 14, 2018ImmuPharma announces positive pre-clinical data on its CIDP programme Read More June 06, 2018Annual Report and Accounts Posted to Shareholders Read More May 29, 2018Further Analysis from its Pivotal Phase III Trial of Lupuzor™ in Patients with Systemic Lupus Erythematosus (SLE) Shows Positive Results in the Europe Cohort<sup>1</sup> Read More April 24, 2018Holding in company Read More April 23, 2018Immupharma PLC confident on Lupuzor’s™ future Read More April 19, 2018Holding in company Read More April 18, 2018Holding in company Read More April 17, 2018Top line results of Lupuzor™ Pivotal Phase III Trial Read More March 28, 2018Appointment of Joint Broker Read More March 23, 2018Lupuzor™ ‘database lock’ confirmed for 6 April 2018 Read More 1…1213141516
May 29, 2018Further Analysis from its Pivotal Phase III Trial of Lupuzor™ in Patients with Systemic Lupus Erythematosus (SLE) Shows Positive Results in the Europe Cohort<sup>1</sup> Read More
